PT - JOURNAL ARTICLE AU - Facundo Garcia-Bournissen AU - Alon Shrim AU - Gideon Koren TI - Safety of gadolinium during pregnancy. DP - 2006 Mar 01 TA - Canadian Family Physician PG - 309--310 VI - 52 IP - 3 4099 - http://www.cfp.ca/content/52/3/309.short 4100 - http://www.cfp.ca/content/52/3/309.full SO - Can Fam Physician2006 Mar 01; 52 AB - QUESTION: A pregnant patient who underwent magnetic resonance imaging (MRI) because of an acute abdomen, was told that MRI contrast agents (ie, gadolinium-based contrast agents) are contraindicated during pregnancy. What is the risk to her baby? ANSWER: Current radiology practices and recommendations discourage the use of gadolinium-based contrast agents during pregnancy because their safety for the fetus has not yet been proven. In line, however, with the European Society of Radiology guidelines and based on the available evidence, gadolinium-based contrast agents appear to be safe in pregnancy. Gadolinium use should be considered when the diagnostic study is important for the health of the mother.